Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Juan Antonio García-Carmona & Sofia Pappa. (2023) Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal. Drug, Healthcare and Patient Safety 15, pages 113-123.
Read now
Read now
Antoine C. El Khoury, Dominic Pilon, Laura Morrison, Nina Shak, Maude Vermette-Laforme, Tony B. Amos, Edward Kim & Patrick Lefebvre. (2019) The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia. Current Medical Research and Opinion 35:3, pages 395-405.
Read now
Read now
Miquel Bioque & Miquel Bernardo. (2018) The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia. Expert Opinion on Pharmacotherapy 19:14, pages 1623-1629.
Read now
Read now
Solomon Nuhoho, Abdallah Saad, Goretti Saumell, Daniel Ribes & Antoine C. El Khoury. (2018) Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates. Current Medical Research and Opinion 34:4, pages 601-611.
Read now
Read now
Thomas R. Einarson, Basil G. Bereza, Fadi Tedouri, Kristel Van Impe, Tom R. Denee & Pieter J. T. Dries. (2017) Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands. Journal of Medical Economics 20:11, pages 1187-1199.
Read now
Read now
Thomas R. Einarson, Basil G. Bereza, Ignacio Garcia Llinares, Beatriz González Martín Moro, Fadi Tedouri & Kristel Van Impe. (2017) Cost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain. Journal of Medical Economics 20:10, pages 1039-1047.
Read now
Read now
Miquel Bernardo & Miquel Bioque. (2016) Three-month paliperidone palmitate - a new treatment option for schizophrenia. Expert Review of Clinical Pharmacology 9:7, pages 899-904.
Read now
Read now
Articles from other publishers (7)
Grace Hsin-Min WangMikael SvenssonHui ShaoScott Martin VouriHaesuk Park. (2023) Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia. Journal of Managed Care & Specialty Pharmacy 29:8, pages 884-895.
Crossref
Crossref
Benjamin Kearns, Katy Cooper, Martin Orr, Munira Essat, Jean Hamilton & Anna Cantrell. (2022) The Incidence and Costs of Adverse Events Associated with Antidepressants: Results from a Systematic Review, Network Meta-Analysis and Multi-Country Economic Model. Neuropsychiatric Disease and Treatment Volume 18, pages 1133-1143.
Crossref
Crossref
Luying Wang, Fenghao Shi, Xin Guan, He Xu, Jing Liu & Hongchao Li. (2021) A Systematic Review of Methods and Study Quality of Economic Evaluations for the Treatment of Schizophrenia. Frontiers in Public Health 9.
Crossref
Crossref
Huajie Jin, Paul Tappenden, Stewart Robinson, Evanthia Achilla, James H. MacCabe, David Aceituno & Sarah Byford. (2020) A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway. PharmacoEconomics 38:6, pages 537-555.
Crossref
Crossref
Antoine C. El KhouryDominic PilonLaura MorrisonNina Shak, Amanda LlanezaEdward KimPatrick Lefebvre. (2020) Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia. Journal of Managed Care & Specialty Pharmacy 26:2, pages 176-185.
Crossref
Crossref
Margareth R.C. Marques, Qiuyi Choo, Mukul Ashtikar, Thais Correa Rocha, Susanne Bremer-Hoffmann & Matthias G. Wacker. (2019) Nanomedicines - Tiny particles and big challenges. Advanced Drug Delivery Reviews 151-152, pages 23-43.
Crossref
Crossref
Athanasia Papadopoulou, Kitsos Gkikas, Vasiliki Efstathiou, Ilias Gkikas, Styliani Kokoris, Vasiliki Lagari, Charalabos Papageorgiou, Athanasios Douzenis, Nikolaos Siafakas & Emmanouil N. Rizos. (2017) Angioedema Associated With Long-Acting Injectable Paliperidone Palmitate. Journal of Clinical Psychopharmacology 37:6, pages 730-732.
Crossref
Crossref